← Leaderboards
Robert John Wilkinson
University Of Cape Town
$5,301,802
Attributed
$12,041,833
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,041,833 · 5
By mechanism
R01$8,772,066 · 2
U01$2,098,576 · 2
UH2$1,171,191 · 1
Top collaborators
- Martin Alfons Gengenbacher7 shared
- Alan Sher6 shared
- Daniel Leo Barber5 shared
- Mpiko Ntsekhe5 shared
- Rachel Pei Jen Lai3 shared
- Veronique Dartois2 shared
- Joanne L. Flynn2 shared
- Christopher M Sassetti2 shared
Most similar at University Of Cape Town
Same institution · by research overlap
- Anna-Lise Williamson$1,254,747
- Daniel Leo Barber$333,323
- Mpiko Ntsekhe$1,390,313
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionMycobacterium TuberculosisTuberculosisResponseImmune ResponseTissuesInflammationMouse ModelTuberculosis TreatmentCytokineSiteBiological MarkersPlasmaCollaborationsSafetyBloodPharmacotherapyImmunologicsPhenotypeIn VitroPathogenesisTuberculosis DrugsMacrophage
Grant awards (22)
Influence of high-dose rifampin on Mycobacterial load and inflammatory mediators in pericardial TB patients$199,994
U01 · FY2025 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection$1,273,323
R01 · FY2024 · AI
Translational approaches to improve understanding and outcome in Tuberculous meningitis$747,157
R01 · FY2024 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection$1,276,503
R01 · FY2023 · AI
Translational approaches to improve understanding and outcome in Tuberculous meningitis$703,053
R01 · FY2023 · AI
Influence of high-dose rifampin on Mycobacterial load and inflammatory mediators in pericardial TB patients$199,994
U01 · FY2023 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection$1,294,431
R01 · FY2022 · AI
Translational approaches to improve understanding and outcome in Tuberculous meningitis$693,318
R01 · FY2022 · AI
Influence of high-dose rifampin on Mycobacterial load and inflammatory mediators in pericardial TB patients$199,994
U01 · FY2022 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection$1,297,094
R01 · FY2021 · AI
Translational approaches to improve understanding and outcome in Tuberculous meningitis$736,322
R01 · FY2021 · AI
Influence of high-dose rifampin on Mycobacterial load and inflammatory mediators in pericardial TB patients$199,994
U01 · FY2021 · AI
Translational approaches to improve understanding and outcome in Tuberculous meningitis$750,865
R01 · FY2020 · AI
Influence of high-dose rifampin on Mycobacterial load and inflammatory mediators in pericardial TB patients$199,994
U01 · FY2020 · AI
Inflammatory determinants of disease severity and treatment outcome in TB patients$151,636
U01 · FY2019 · AI · contact PI
Inflammatory determinants of disease severity and treatment outcome in TB patients$296,865
U01 · FY2018 · AI · contact PI
Inflammatory determinants of disease severity and treatment outcome in TB patients$162,700
U01 · FY2017 · AI · contact PI
Inflammatory determinants of disease severity and treatment outcome in TB patients$147,254
U01 · FY2017 · AI · contact PI
Rational Design of Combination Regimens Targeting Both Host and Pathogen$571,191
UH2 · FY2016 · AI
Inflammatory determinants of disease severity and treatment outcome in TB patients$165,437
U01 · FY2016 · AI · contact PI
Rational Design of Combination Regimens Targeting Both Host and Pathogen$600,000
UH2 · FY2015 · AI
Inflammatory determinants of disease severity and treatment outcome in TB patients$174,714
U01 · FY2015 · AI · contact PI